Sign In
Nifty Pharma Surges 4.5% as Trump's Reciprocal Tariffs Exclude Sector; Gland Pharma, Dr. Reddy’s Rally 10%
US Tariffs: Citi Sees Minimal Impact On Indian Pharma Firms
Pharma Stocks and Trump's Proposed 35% Tariffs: Potential Impact on Sun Pharma, DRL, and Aurobindo
US tariffs: Global brokerage firm Citi sees minimal impact on Indian pharma firms
Indian Pharma To Gain Amid Higher US Tariffs
What Can Be Done To Address Growing Vaccine Scepticism?
Pharma Cos Under Govt Lens For Quality Issues
USV launches new product for diabetes care in India
Eli Lilly launches Weight Loss Drug Mounjaro in India
Tobacco May Well Be The Future Of Pharmaceutical Production
Hyd’s Utopia Working On Obesity Vaccine
Indian Generic Drugs Meet Global Standards
